Process-1st
Process-1st provides a sales intelligence platform for pharma and bioprocess sales teams, mapping facility-level data into ranked, product-specific recommendations for biologics manufacturing sites. The platform builds detailed models of each customer facility—including modalities, processes, and equipment profiles—and delivers Site Intelligence Reports with pre-call briefs, competitor analysis, and SORA sales strategies. It achieves 94.2% signal accuracy on FDA-registered biologics sites with time to first insight under 48 hours.
- Sales Technology
- Data & Analytics
- Artificial Intelligence
- Software Only
- Biotechnology
- Healthcare Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Pharma sales representatives often know their quotas but rarely know which specific products a given manufacturing facility actually needs. Territory-level averages and guesswork lead to unfocused sales conversations, wasted calls, and missed opportunities at sites with distinct modalities, processes, and equipment profiles.
Solution
Process-1st delivers a sales intelligence platform that maps facility-level data into ranked, product-specific recommendations for bioprocess sales teams. The platform builds a detailed model of each customer site—including its modalities, processes, and equipment profile—and matches it against an industry-expert-built map of biologics manufacturing requirements. It derives which products from a vendor's portfolio are most likely needed at that specific site, ranked by confidence, and packages them into a Site Intelligence Report with a one-page pre-call brief. The system also provides competitor intelligence, portfolio gap analysis, and a SORA (Situation, Opportunity, Risk, Action) sales strategy for each account.
Target Audience
Primary customers are pharmaceutical and life sciences sales teams, particularly bioprocess sales representatives and account managers selling equipment, consumables, and reagents to biologics manufacturing facilities.
Features
- Site-level precision derived from facility-specific modalities, processes, and equipment profiles, not territory averages
- Product-specific signals ranked by likelihood of need at each individual site
- Intelligence Engine combining five layers of AI and data, including facility descriptions, detailed process maps, vendor portfolios, salesperson input, and a process-selling LLM
- Coverage of all major biologics modalities, including mAbs, biosimilars, microbials, bi-specifics, fusion proteins, and complex peptides
- Comprehensive Site Intelligence Reports with facility profile, pipeline analysis, process maps, competitor analysis, and incumbent vendor intelligence
- Sales Strategy (SORA) framework with ranked next steps and pre-call talking points tailored to each account's pipeline and timeline
- Ignition Services for bespoke engineering opportunities, providing concept-to-quote project execution
- Time to first insight under 48 hours, with signal accuracy of 94.2% on FDA-registered biologics sites